“Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study”. The Review of Diabetic Studies , Sept. 2025, pp. 693-00, https://doi.org/10.70082/qs5vrk14.